| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Arsenic Trioxide in Treating Patients With Advanced Solid Tumors (NCT00003630) | Memorial Sloan Kettering Cancer Center | 1998-08-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003698) | University of Glasgow | 1998-07-01 |
| Interleukin-12 in Treating Patients With Advanced Cancer (NCT00003330) | National Cancer Institute (NCI) | 1998-07-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003708) | The University of Texas Health Science Center at San Antonio | 1998-07-01 |
| Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003555) | State University of New York - Upstate Medical University | 1998-07-01 |
| Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687) | NCIC Clinical Trials Group | 1998-06-11 |
| Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (NCT00003368) | National Cancer Institute (NCI) | 1998-06-01 |
| Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00009802) | University of Pittsburgh | 1998-06-01 |
| Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy (NCT00019357) | National Cancer Institute (NCI) | 1998-06-01 |
| UCN-01 in Treating Patients With Advanced Cancer (NCT00003289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-06-01 |
| 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors (NCT00004213) | Vion Pharmaceuticals | 1998-05-01 |
| Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers (NCT00003249) | National Cancer Institute (NCI) | 1998-05-01 |
| Combination Chemotherapy In Treating Patients With Advanced Cancer (NCT00003925) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Fenretinide in Treating Patients With Solid Tumors (NCT00003250) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| T138067 Sodium in Treating Patients With Advanced Refractory Cancer (NCT00003359) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function (NCT00003706) | The University of Texas Health Science Center at San Antonio | 1998-04-01 |
| L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003430) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| E7070 in Treating Patients With Solid Tumors (NCT00003981) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-04-01 |
| Theophylline in Treating Cancer Patients With Shortness of Breath (NCT00003684) | NCIC Clinical Trials Group | 1998-03-24 |
| E7070 in Treating Patients With Solid Tumors (NCT00003976) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-03-01 |
| EF5 in Treating Patients With Solid Tumors (NCT00003282) | National Cancer Institute (NCI) | 1998-03-01 |
| Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00008125) | University of Pittsburgh | 1998-03-01 |
| Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00003269) | Scripps Health | 1998-02-01 |
| Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00003242) | Memorial Sloan Kettering Cancer Center | 1998-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003331) | NYU Langone Health | 1998-01-01 |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (NCT00003125) | Georgetown University | 1998-01-01 |
| Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer (NCT00003132) | NYU Langone Health | 1998-01-01 |
| Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy (NCT00003252) | Rush North Shore Medical Center | 1997-12-01 |
| Green Tea Extract in Treating Patients With Advanced Solid Tumors (NCT00003197) | Memorial Sloan Kettering Cancer Center | 1997-12-01 |
| Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors (NCT00003109) | Fox Chase Cancer Center | 1997-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (NCT00003082) | University of Arizona | 1997-12-01 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036) | The Cleveland Clinic | 1997-11-01 |
| BMS-184476 in Treating Patients With Advanced Solid Tumors (NCT00003705) | San Antonio Cancer Institute | 1997-11-01 |
| Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors (NCT00021346) | Fox Chase Cancer Center | 1997-11-01 |
| Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors (NCT00003198) | Memorial Sloan Kettering Cancer Center | 1997-11-01 |
| Paclitaxel in Treating Women With Recurrent Solid Tumors (NCT00003130) | Alliance for Clinical Trials in Oncology | 1997-11-01 |
| Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors (NCT00003038) | Mayo Clinic | 1997-10-01 |
| Penclomedine in Treating Patients With Solid Tumors or Lymphoma (NCT00002946) | National Cancer Institute (NCI) | 1997-10-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer (NCT00003108) | Lombardi Comprehensive Cancer Center | 1997-10-01 |
| Paclitaxel in Treating Older Patients With Solid Tumors (NCT00003092) | Alliance for Clinical Trials in Oncology | 1997-09-01 |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors (NCT00003173) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors (NCT00003711) | San Antonio Cancer Institute | 1997-09-01 |
| Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00003713) | Genzyme, a Sanofi Company | 1997-08-01 |
| Flavopiridol in Treating Patients With Refractory Cancer (NCT00019344) | National Cancer Institute (NCI) | 1997-08-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Bizelesin in Treating Patients With Advanced Cancer (NCT00003021) | The University of Texas Health Science Center at San Antonio | 1997-08-01 |
| Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003144) | NYU Langone Health | 1997-08-01 |
| Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors (NCT00002994) | Alliance for Clinical Trials in Oncology | 1997-07-01 |
| MEN-10755 in Treating Patients With Solid Tumors (NCT00003982) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-06-01 |
| Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (NCT00002980) | California Cancer Consortium | 1997-05-01 |
| Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer (NCT00003294) | Roswell Park Cancer Institute | 1997-05-01 |
| KRN5500 in Treating Patients With Metastatic Solid Tumors (NCT00002923) | Barbara Ann Karmanos Cancer Institute | 1997-05-01 |
| MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors (NCT00003028) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-04-01 |
| Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors (NCT00002902) | Abramson Cancer Center at Penn Medicine | 1997-04-01 |
| Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction (NCT00540982) | City of Hope Medical Center | 1997-02-20 |
| Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma (NCT00002909) | National Cancer Institute (NCI) | 1997-02-01 |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function (NCT00002901) | City of Hope Medical Center | 1996-12-01 |
| Penclomedine in Treating Patients With Advanced Solid Tumors (NCT00002915) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1996-12-01 |
| Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer (NCT00002939) | University of Chicago | 1996-11-01 |
| Perillyl Alcohol in Treating Patients With Refractory Cancer (NCT00002862) | National Cancer Institute (NCI) | 1996-10-01 |
| Dietary Soy Isoflavones for the Prevention of Cancer (NCT00003100) | Children's Hospital Medical Center, Cincinnati | 1996-10-01 |
| Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer (NCT00002950) | Yale University | 1996-09-26 |
| Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma (NCT00005021) | Fox Chase Cancer Center | 1996-07-01 |
| Heparin or Enoxaparin in Patients With Cancer (NCT00004875) | Northwestern University | 1996-07-01 |
| Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma (NCT00002759) | National Cancer Institute (NCI) | 1996-06-01 |
| Drugs to Reduce the Side Effects of Chemotherapy (NCT00003213) | Swiss Cancer Institute | 1996-05-01 |
| VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin (NCT00004030) | Georgetown University | 1996-03-01 |
| Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer (NCT00003009) | University of Southern California | 1996-02-01 |
| Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors (NCT00002904) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-02-01 |
| Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00008086) | University of Pittsburgh | 1996-01-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00002733) | Hoag Memorial Hospital Presbyterian | 1996-01-01 |
| O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors (NCT00002604) | Case Comprehensive Cancer Center | 1996-01-01 |
| Octreotide and Doxorubicin in Treating Patients With Advanced Cancer (NCT00008073) | University of Pittsburgh | 1996-01-01 |
| Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors (NCT00003697) | University of Glasgow | 1995-10-01 |
| Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors (NCT00002677) | University of Maryland, Baltimore | 1995-08-01 |
| Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas (NCT00019019) | National Institutes of Health Clinical Center (CC) | 1994-10-01 |
| Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors (NCT00002587) | National Cancer Institute (NCI) | 1994-09-01 |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate (NCT00018967) | National Cancer Institute (NCI) | 1993-11-01 |
| Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer (NCT00002943) | Wake Forest University Health Sciences | 1993-02-01 |
| Tumor Cell Vaccine in Treating Patients With Advanced Cancer (NCT00002505) | Hoag Memorial Hospital Presbyterian | 1992-08-01 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer (NCT00002482) | St. Vincent Medical Center - Los Angeles | 1991-06-01 |
| Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520) | Eastern Cooperative Oncology Group | 1990-12-07 |
| S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors (NCT00788580) | SWOG Cancer Research Network | |
| BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment (NCT00005611) | H. Lee Moffitt Cancer Center and Research Institute | |
| Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer (NCT00093678) | Eastern Cooperative Oncology Group | |
| Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease (NCT00005024) | Jonsson Comprehensive Cancer Center | |
| Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors (NCT00004979) | Jonsson Comprehensive Cancer Center | |
| Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00072228) | Daiichi Pharmaceuticals | |
| SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00005996) | Jonsson Comprehensive Cancer Center | |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |
| Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00023816) | Jonsson Comprehensive Cancer Center | |
| Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer (NCT00607802) | Wake Forest University Health Sciences | |
| Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy (NCT01473290) | Alliance for Clinical Trials in Oncology | |